The role of interleukin-2 during homeostasis and activation of the immune system

被引:1253
作者
Boyman, Onur [1 ,2 ]
Sprent, Jonathan [3 ,4 ]
机构
[1] Univ Zurich, Lab Appl Immunobiol, CH-8006 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland
[3] Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia
[4] POSTECH, WCU IBB Program, Pohang, South Korea
基金
瑞士国家科学基金会; 新加坡国家研究基金会; 英国医学研究理事会;
关键词
REGULATORY T-CELLS; MOUSE DENDRITIC CELLS; RECEPTOR-BETA-CHAIN; IN-VIVO EXPANSION; IL-2; PRODUCTION; MONOCLONAL-ANTIBODY; CUTTING EDGE; SELECTIVE STIMULATION; DOSE INTERLEUKIN-2; ANTITUMOR-ACTIVITY;
D O I
10.1038/nri3156
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-2 (IL-2) signals influence various lymphocyte subsets during differentiation, immune responses and homeostasis. As discussed in this Review, stimulation with IL-2 is crucial for the maintenance of regulatory T (T-Reg) cells and for the differentiation of CD4(+) T cells into defined effector T cell subsets following antigen-mediated activation. For CD8(+) T cells, IL-2 signals optimize both effector T cell generation and differentiation into memory cells. IL-2 is presented in soluble form or bound to dendritic cells and the extracellular matrix. Use of IL-2 - either alone or in complex with particular neutralizing IL-2-specific antibodies - can amplify CD8(+) T cell responses or induce the expansion of the T-Reg cell population, thus favouring either immune stimulation or suppression.
引用
收藏
页码:180 / 190
页数:11
相关论文
共 117 条
  • [1] Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175
  • [2] mTOR regulates memory CD8 T-cell differentiation
    Araki, Koichi
    Turner, Alexandra P.
    Shaffer, Virginia Oliva
    Gangappa, Shivaprakash
    Keller, Susanne A.
    Bachmann, Martin F.
    Larsen, Christian P.
    Ahmed, Rafi
    [J]. NATURE, 2009, 460 (7251) : 108 - U124
  • [3] Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections
    Bachmann, Martin F.
    Wolint, Petra
    Walton, Senta
    Schwarz, Katrin
    Oxenius, Annette
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (06) : 1502 - 1512
  • [4] Bae J, 2008, J MICROBIOL BIOTECHN, V18, P377
  • [5] Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome
    Baluna, R
    Rizo, J
    Gordon, BE
    Ghetie, V
    Vitetta, ES
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3957 - 3962
  • [6] Cutting Edge: Mechanisms of IL-2-Dependent Maintenance of Functional Regulatory T Cells
    Barron, Luke
    Dooms, Hans
    Hoyer, Katrina K.
    Kuswanto, Wilson
    Hofmann, Jerry
    O'Gorman, William E.
    Abbas, Abul K.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (11) : 6426 - 6430
  • [7] TIMELINE The Immune Tolerance Network at 10 years: tolerance research at the bedside
    Bluestone, Jeffrey A.
    Auchincloss, Hugh
    Nepom, Gerald T.
    Rotrosen, Daniel
    Clair, E. William St.
    Turka, Laurence A.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (11) : 797 - 803
  • [8] Selective stimulation of T cell subsets with antibody-cytokine immune complexes
    Boyman, O
    Kovar, M
    Rubinstein, MP
    Surh, CD
    Sprent, J
    [J]. SCIENCE, 2006, 311 (5769) : 1924 - 1927
  • [9] Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease
    Boyman, Onur
    Surh, Charles D.
    Sprent, Jonathan
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (12) : 1323 - 1331
  • [10] Boyman O, 2010, ADV EXP MED BIOL, V684, P28